Inventor · disambiguated record
Romain Luc Marie Gosmini
Also filed as: GOSMINI ROMAIN L · GOSMINI ROMAIN LUC · GOSMINI ROMAIN LUC MARIE
19 granted patents·6 pending applications·170 citations·filing 2001–2021
94Inventor score
Files withGALAPAGOS NV6GLAXOSMITHKLINE LLC4LILLY ICOS LLC4SMITHKLINE BEECHAM CORP4DEMONT EMMANUEL HUBERT2
Top patents by PatentIndex Score
25 records- 0192US8580957B2Thetrahydroquinolines derivatives as bromodomain inhibitorsDEMONT EMMANUEL HUBERT·Filed 2010·Granted Nov 12, 2013·29 cites·19 claims
- 0290US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 0389US8697725B2Tetrahydroquinoline derivatives and their pharmaceutical useDEMONT EMMANUEL HUBERT·Filed 2010·Granted Apr 15, 2014·19 cites·17 claims
- 0488US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 0587US9102677B2Benzodiazepine bromodomain inhibitorBAILEY JAMES·Filed 2010·Granted Aug 11, 2015·14 cites·10 claims
- 0684US7338960B2Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activatorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Mar 4, 2008·25 cites·14 claims
- 0783US6838456B2Condensed pyridoindole derivativesLILLY ICOS LLC·Filed 2001·Granted Jan 4, 2005·21 cites·26 claims
- 0881US7105551B2Thiazole derivatives for treating PPAR related disordersSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 12, 2006·10 cites·22 claims
- 0981US7022856B2Carboline derivativesLILLY ICOS LLC·Filed 2001·Granted Apr 4, 2006·18 cites·18 claims
- 1077US6858620B2Condensed pyridoindole derivativesLILLY ICOS LLC·Filed 2001·Granted Feb 22, 2005·11 cites·18 claims
- 1176US6867225B2Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseasesSMITHKLINE BEECHAM CORP·Filed 2002·Granted Mar 15, 2005·10 cites·19 claims
- 1269US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 1368US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 1465US9023842B2Benzodiazepine bromodomain inhibitorGOSMINI ROMAIN LUC MARIE·Filed 2010·Granted May 5, 2015·1 cites·7 claims
- 1565US6984641B2Carboline derivatives as PDE5 inhibitorsLILLY ICOS LLC·Filed 2002·Granted Jan 10, 2006·2 cites·5 claims
- 1659US7439259B2Thiazole derivatives for treating PPAR related disordersSMITHKLINE BEECHAM CORP·Filed 2006·Granted Oct 21, 2008·0 cites·12 claims
- 1751US9598420B2Benzodiazepine bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2015·Granted Mar 21, 2017·0 cites·12 claims
- 1851US2017197972A1Benzodiazepine bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1951US2017145021A1Novel compoundsGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 2046US2015210706A1Benzodiazepine Bromodomain InhibitorGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 2138US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 2238US2004147557A1Aryl piperidine derivatives as inducers of ldl-receptor expressionFiled 2001·Application pending·0 cites
- 2338US2004077654A1Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expressionFiled 2001·Application pending·0 cites
- 2437US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
- 2534US2012202799A1Condensed Azepine Derivatives As Bromodomain InhibitorsCROWE MIRIAM·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →